首页> 外文会议>International conference on product innovation management >Study on the Development Paths of American Biotechnology Pharmaceutical Enterprises and Its Revelation
【24h】

Study on the Development Paths of American Biotechnology Pharmaceutical Enterprises and Its Revelation

机译:美国生物技术药物制药企业发展路径及其启示录

获取原文

摘要

Under the background of biotechnology pharmaceutical industries, the paper choosing four American biotechnology pharmaceutical enterprises as the research subjects: Amgen, Genentech, Biogen and Genzeme . Through analyzing the development course of these enterprises, three typical development paths zre concluded: self-development by means of traditional large-scale enterprises, self-integrated development and ―tie-core‖ incremental development. Meanwhile, the reasons why different enterprises choose different paths are analyzed. At last, revelations for China biotechnology enterprises development path are put forward based on above study and such suggestions aim at different enterprise type.
机译:在生物技术制药行业的背景下,该论文选择了四个美国生物技术药物企业作为研究主题:Amgen,Genentech,BieOne和Genzeme。通过分析这些企业的开发过程,三个典型的发展道路ZRE得出结论:通过传统的大型企业,自我综合的发展和核心的增量发展自我开发。同时,分析了不同企业选择不同路径的原因。最后,基于上述研究,提出了中国生物技术企业发展道路的启示,并提出了不同的企业类型的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号